Thu Jun 16, 2022 – 3:42 pm EDT
(LifeSiteNews) – Pharmaceutical giant Pfizer is asking the U.S. District Court for the Eastern District of Texas to dismiss a whistleblower’s false claims lawsuit on the grounds that its contract with the federal government exempts the company from the laws and regulations it is accused of violating.
Last year, the British Medical Journal published a report on insider information from a former regional director of the medical research company Ventavia, which Pfizer hired in 2020 to conduct research for the company’s mRNA-based COVID-19 vaccine.
The regional director, Brook Jackson, sent BMJ “dozens of internal company documents, photos, audio recordings, and emails,” which “revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety […] We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA [U.S. Food & Drug Administration] did not inspect Ventavia’s trial sites.”
According to the report, Ventavia “falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
